- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Phyllis Torda Championed Improved Quality Measurement Guidelines in Oncology
On February 16, after living with metastatic breast cancer, Phyllis Torda, 63, vice president of the Quality Solutions Group at the National Committee for Quality Assurance, passed away.
On February 16, after living with metastatic breast cancer for 8 years, Phyllis Torda, 63, vice president of the Quality Solutions Group at the National Committee for Quality Assurance (NCQA), passed away.
In November 2014, she attended and sat on a panel at The American Journal of Managed Care’s Patient-Centered Oncology Care meeting. There, she discussed defining quality in oncology care and shortcomings in current guidelines for measuring quality in cancer care.
“Quality measure construction has to be really precise,” she said in an interview. “You have to say what you can do and what you can’t do. And so in order for the guidelines to be really helpful for quality measure construction, they need to be more precise than they are now.”
While there are efforts in preventive services to better coordinate the work between guideline and measurement developers, no such movement is going on in oncology. However, Ms Torda thought it might come up in the near future.
She also discussed how to get cancer patients more involved in quality measurements at 3 different levels: as an individual patient, through a patient advisory committee offering constructive criticism to practices, and, finally, at the policy or advocacy level.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More
